Ftse Mib
33.633,39
-2,07%
DAX
19.033,64
-2,14%
S&P 500
5.983,99
-0,29%
NASDAQ
19.281,40
-0,09%
Bitcoin
88.377,71
-0,42%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX iBio Inc (IBIO) iBio Inc (IBIO) Notizie

iBio Inc

IBIO
2,57
0,025 (0,98%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:05:51
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:06EDGAR2Form 8-K - Current report
12/11/202422:05GLOBEiBio Reports Fiscal First Quarter 2025 Financial Results
23/10/202415:12EDGAR2Form 8-K - Current report
10/10/202422:16EDGAR2Form ARS - Annual Report to Security Holders
10/10/202422:10EDGAR2Form DEF 14A - Other definitive proxy statements
10/10/202414:00GLOBEiBio and AstralBio Provide Update on Myostatin Program for..
24/9/202422:11EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20/9/202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/9/202422:07EDGAR2Form 8-K - Current report
20/9/202422:05GLOBEiBio Reports Fiscal Year 2024 Financial Results and Provides..
03/9/202413:00GLOBEiBio to Participate in Upcoming Investor Conferences
12/8/202422:30GLOBEiBio Expands Executive Leadership Team with Appointment of..
06/8/202423:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/7/202415:03EDGAR2Form 8-K - Current report
25/7/202423:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
09/7/202422:02EDGAR2Form 8-K - Current report
05/6/202422:10EDGAR2Form 8-K - Current report
03/6/202422:08EDGAR2Form 8-K - Current report
03/6/202413:00GLOBEiBio Closes Sale of Manufacturing Facility in Texas
20/5/202412:55EDGAR2Form 8-K - Current report
13/5/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:08EDGAR2Form 8-K - Current report
13/5/202422:05GLOBEiBio Reports Fiscal Third Quarter 2024 Financial Results and..
27/3/202412:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
27/3/202400:35GLOBEiBio Announces $15.0 Million Private Placement
26/2/202413:59EDGAR2Form 8-K - Current report
26/2/202413:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
21/2/202422:55EDGAR2Form 8-K - Current report
19/1/202422:36EDGAR2Form 8-K - Current report
16/1/202414:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
10/1/202419:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202422:30EDGAR2Form 8-K - Current report
04/1/202414:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/12/202313:44EDGAR2Form 8-K - Current report
26/12/202313:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
08/12/202322:17EDGAR2Form 8-K - Current report
06/12/202315:13EDGAR2Form 8-K - Current report
06/12/202314:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/12/202314:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
30/11/202314:55EDGAR2Form S-1/A - General form for registration of securities..
28/11/202314:36EDGAR2Form 8-K - Current report
27/11/202323:20GLOBEiBio Announces Reverse Stock Split
Apertura: 2,58 Min: 2,335 Max: 2,59
Chiusura: 2,545

La tua Cronologia

AMEX
IBIO
iBio
NASDAQ
IKAN
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network